Cargando…
Inhibition of castration-resistant prostate cancer growth by genistein through suppression of AKR1C3
BACKGROUND: Prostate cancer is the second leading cause of cancer-related death among males in America. The patients’ survival time is significantly reduced after prostate cancer develops into castration-resistant prostate cancer (CRPC). It has been reported that AKR1C3 is involved in this progressi...
Autores principales: | Yu, Xiaoping, Yan, Jiali, Li, Yulu, Cheng, Jing, Zheng, Lujie, Fu, Tianyu, Zhu, Yanfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Academia
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899042/ https://www.ncbi.nlm.nih.gov/pubmed/36794010 http://dx.doi.org/10.29219/fnr.v67.9024 |
Ejemplares similares
-
siAKR1C3@PPA complex nucleic acid nanoparticles inhibit castration-resistant prostate cancer in vitro
por: Cui, Xiaoli, et al.
Publicado: (2022) -
Genistein Suppresses Prostate Cancer Growth through Inhibition of Oncogenic MicroRNA-151
por: Chiyomaru, Takeshi, et al.
Publicado: (2012) -
20(S)-Protopanaxadiol Inhibition of Progression and Growth of Castration-Resistant Prostate Cancer
por: Cao, Bo, et al.
Publicado: (2014) -
AKR1C3 Inhibition Therapy in Castration-Resistant Prostate Cancer and Breast Cancer: Lessons from Responses to SN33638
por: Zhou, Wen, et al.
Publicado: (2014) -
Suppression of lymphoma growth by the xenoestrogens bisphenol A and genistein
por: Yakimchuk, Konstantin, et al.
Publicado: (2018)